Genes and compounds that increase type VII collagen expression as potential treatments for dystrophic epidermolysis bullosa
Sign Up to like & getrecommendations! Published in 2022 at "Experimental Dermatology"
DOI: 10.1111/exd.14555
Abstract: Dystrophic epidermolysis bullosa (DEB) is a skin‐blistering disease caused by mutations in COL7A1, which encodes type VII collagen (C7). There is no cure for DEB, but previous work has shown potential therapeutic benefit of increased… read more here.
Keywords: vii collagen; epidermolysis bullosa; compounds increase; expression ... See more keywords